365 related articles for article (PubMed ID: 11002274)
1. Liquid chromatography-mass spectrometry in the study of the metabolism of drugs and other xenobiotics.
Oliveira EJ; Watson DG
Biomed Chromatogr; 2000 Oct; 14(6):351-72. PubMed ID: 11002274
[TBL] [Abstract][Full Text] [Related]
2. Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies.
Kostiainen R; Kotiaho T; Kuuranne T; Auriola S
J Mass Spectrom; 2003 Apr; 38(4):357-72. PubMed ID: 12717747
[TBL] [Abstract][Full Text] [Related]
3. High-throughput quantitative bioanalysis by LC/MS/MS.
Jemal M
Biomed Chromatogr; 2000 Oct; 14(6):422-9. PubMed ID: 11002279
[TBL] [Abstract][Full Text] [Related]
4. The impact of recent innovations in the use of liquid chromatography-mass spectrometry in support of drug metabolism studies: are we all the way there yet?
Nassar AE; Talaat RE; Kamel AM
Curr Opin Drug Discov Devel; 2006 Jan; 9(1):61-74. PubMed ID: 16445118
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS.
Xu RN; Fan L; Rieser MJ; El-Shourbagy TA
J Pharm Biomed Anal; 2007 Jun; 44(2):342-55. PubMed ID: 17360141
[TBL] [Abstract][Full Text] [Related]
6. Strategies for characterization of drug metabolites using liquid chromatography-tandem mass spectrometry in conjunction with chemical derivatization and on-line H/D exchange approaches.
Liu DQ; Hop CE
J Pharm Biomed Anal; 2005 Feb; 37(1):1-18. PubMed ID: 15664738
[TBL] [Abstract][Full Text] [Related]
7. High-performance liquid chromatography-mass spectrometry (HPLC-MS)-based drug metabolite profiling.
Wilson ID
Methods Mol Biol; 2011; 708():173-90. PubMed ID: 21207290
[TBL] [Abstract][Full Text] [Related]
8. Microfluidic chip-based liquid chromatography coupled to mass spectrometry for determination of small molecules in bioanalytical applications.
Lin SL; Bai HY; Lin TY; Fuh MR
Electrophoresis; 2012 Feb; 33(4):635-43. PubMed ID: 22451056
[TBL] [Abstract][Full Text] [Related]
9. Micro LC/MS in drug analysis and metabolism studies.
Henion J; Skrabalak D; Dewey E; Maylin G
Drug Metab Rev; 1983; 14(5):961-1003. PubMed ID: 6360611
[TBL] [Abstract][Full Text] [Related]
10. Ultrafast liquid chromatography/ultraviolet and liquid chromatography/tandem mass spectrometric analysis.
Cheng Y; Lu Z; Neue U
Rapid Commun Mass Spectrom; 2001; 15(2):141-51. PubMed ID: 11180543
[TBL] [Abstract][Full Text] [Related]
11. Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review.
Roux A; Lison D; Junot C; Heilier JF
Clin Biochem; 2011 Jan; 44(1):119-35. PubMed ID: 20800591
[TBL] [Abstract][Full Text] [Related]
12. Application of LC-MS for quantitative analysis and metabolite identification of therapeutic oligonucleotides.
Lin ZJ; Li W; Dai G
J Pharm Biomed Anal; 2007 Jun; 44(2):330-41. PubMed ID: 17339091
[TBL] [Abstract][Full Text] [Related]
13. Recent trends in the liquid chromatography-mass spectrometry analysis of organic contaminants in environmental samples.
Petrovic M; Farré M; de Alda ML; Perez S; Postigo C; Köck M; Radjenovic J; Gros M; Barcelo D
J Chromatogr A; 2010 Jun; 1217(25):4004-17. PubMed ID: 20334864
[TBL] [Abstract][Full Text] [Related]
14. An introduction to hybrid ion trap/time-of-flight mass spectrometry coupled with liquid chromatography applied to drug metabolism studies.
Liu ZY
J Mass Spectrom; 2012 Dec; 47(12):1627-42. PubMed ID: 23280752
[TBL] [Abstract][Full Text] [Related]
15. LC/MS applications in drug development.
Lee MS; Kerns EH
Mass Spectrom Rev; 1999; 18(3-4):187-279. PubMed ID: 10568041
[TBL] [Abstract][Full Text] [Related]
16. Recent studies on the electrospray ionisation mass spectrometric behaviour of selected nitrogen-containing drug molecules and its application to drug analysis using liquid chromatography-electrospray ionisation mass spectrometry.
Smyth WF
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):1-20. PubMed ID: 16095984
[TBL] [Abstract][Full Text] [Related]
17. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
[TBL] [Abstract][Full Text] [Related]
18. The use of liquid chromatography-mass spectrometry for the identification of drug degradation products in pharmaceutical formulations.
Wu Y
Biomed Chromatogr; 2000 Oct; 14(6):384-96. PubMed ID: 11002276
[TBL] [Abstract][Full Text] [Related]
19. Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology.
Maurer HH
Clin Biochem; 2005 Apr; 38(4):310-8. PubMed ID: 15766732
[TBL] [Abstract][Full Text] [Related]
20. Analytical strategies for identifying drug metabolites.
Prakash C; Shaffer CL; Nedderman A
Mass Spectrom Rev; 2007; 26(3):340-69. PubMed ID: 17405144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
